Lungpacer Medica l today announced the appointment of Kevin Kearney as Chief Commercial Officer (CCO). Kearney brings over 20 ...
Sinopharm is transforming into a one-stop distribution service provider by offering more value-added services along the distribution chain. For instance, it provides inventory management services for ...
Tampa private equity firm HealthEdge Partners has exited one of its longtime investments in a deal with multibillion-dollar ...
However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...
The company's product is used to quickly delivery fluid and blood to patients suffering from life-threatening conditions.
Revenue of $3.3 Million, a 12% Increase Compared to Prior Year ~~ Interim Analysis from MAINSAIL Study Reinforces Safety Profile, Effectiveness and Confirmation of Fusion ~~ Catamaran® ...
Rockwell Medical's annual report on Form 10-K for the year ended December 31, 2024 was filed prior to this call and provides a full analysis of the company's business strategy as well as the company's ...
The fund posted returns of -8.85% (Institutional shares) and -8.93% (Investor A shares, without sales charge) for the fourth ...
5d
Zacks Investment Research on MSN3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA SloganPresident Trump has been vocal about prioritizing the growth of U.S. companies and citizens since his campaigning days. The ...
Boston Scientific Corporation (BSX) is gaining investor attention, including Marshall Wace LLP, which holds nearly $792 ...
Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results